Autopsy report · NCT00722800

A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

“Poor recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 3 years 2 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 2 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Hidradenitis Suppurativa

Interventions

drospirenone and ethinyl estradiol (YAZ); Placebo

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Pilot RCT Evaluating a One Stop Vein Clinic
  “Very poor recruitment” (95% match in meaning)
• Prospective Evaluation of Quality of Life in Patients With Acute Colonic Diverticular Disease
  “poor recruitment status” (93% match in meaning)
• Intrauterine Device Insertion Pain Management
  “Inadequate recruitment” (92% match in meaning)
• Is Interval Appendectomy Necessary?
  “Low recruitment” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.